We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Fusion Ip | FIP | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 92.00 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 92.00 |
| Top Posts |
|---|
Posted at 13/2/2014 14:02 by praipus Tissue Regenix (TRX) have a direct investment from IPO in the form of the "IP Venture Fund" which is a JV joint venture with "EIF European Ivestment Fund".Invesco are usually a fairly passive instititutional investor and are a good indicator IMHO of well researched long term potential. IPO also invest under the name of: IP Group Plc IP2IPO Group PLC IP Group IP Venture Fund Techtran Group Limited (Edit after Bamboo2's post on TRX thread) |
Posted at 03/9/2013 08:32 by ceohunter video interviewFusion IP expects a greater number of companies to join its portfolio every year University commercialisation company Fusion IP's CEO David Baynes told Proactive Investors that he hopes that over the course of the next year they will probably be three to four new companies joining Fusion's portfolio. |
Posted at 24/5/2013 13:41 by andrbea some funds then for investee company, Absynth BiologicsABINGDON, England, May 3, 2013 /PRNewswire/ -- OBN, the trade association supporting and bringing together the UK's emerging life sciences companies, their corporate partners and investors, has welcomed the allocation thus far of £63m in funding awards to UK life science companies under the Biomedical Catalyst (BMC) scheme administered by the Technology Strategy Board (TSB), during its first 12 months of operation. OBN now calls for the BMC's extension at the same level of investment for a minimum duration of the remainder of the UK Life Sciences Strategy, which began late in 2011 and which the Government announced in the Autumn, would have a 10-year duration. OBN Member Companies who have thus far been winners of BioMedical Catalyst funding include PsiOxus Therapeutics, Absynth Biologics, KalVista Pharmaceuticals, PhotoBiotics, Oxford BioTherapeutics, Integrated Magnetic Systems, F-Star Biotechnology, Glide Pharma, Prosonix, mapmyhealth, Arecor, Pharminox, Domainex, Summit Corporation, GeneFirst, Pharmidex, Team Consulting and Gentronix. |
Posted at 15/4/2013 14:39 by tradervic David Baynes appearing again at a Shares event.David Baynes, Chief Executive Officer of Fusion IP (FIP) (FIP.L) [LON:FIP] the university IP commercialisation company, will be presenting at the Shares Magazine Innovation & Growth Investor Evening in London on 9th May 2013. The Innovation & Growth Investor Evening will showcase up to 4 leading innovative and imaginative growth companies bringing them together in one room for one evening only! The event offers a unique opportunity not only to hear about their latest plans but also for investors to put questions to senior management of the companies. Presenting at the event will be Fusion IP (LON:FIP), TyraTech (LON:TYR) and VALIRX (LON:VAL). More details at or |
Posted at 11/1/2013 11:06 by tradervic David Baynes, CEO of Fusion IP to present at the London Innovators and Investors ForumIt is our pleasure to invite you to attend the forthcoming Innovators & Investors Forum on the 29th January 2013 at the Business Design Centre, London. This will be an exclusive invitation only event organised by Shares Magazine and Cenkos Securities. As an active private investor, we are sure you would appreciate this unique opportunity to receive privileged access to 30 diverse, forward thinking and energetic technology companies at a single event. Many of the exhibiting companies are currently involved in some very exciting projects in an effort to drive future growth, and development within their industries. The event will be supported with an extensive conference program, including keynote speakers and company presentations. We sincerely hope you are able to attend and that you find the experience both profitable and enlightening. Companies represented include: 1Spatial Avanti Communications Bango Bond International Software Group Brady CML Microsystems Corac Cyan Holdings eg Solutions Energetix Group eServGlobal Forbidden Technologies Fusion IP Globo incadea InternetQ IQE KBC Advanced Technologies Netcall Optimal Payments Plastics Capital Probability Quindell Portfolio StatPro Group WANdisco Event time: 12.30pm to 5.30pm Complimentary refreshments and luncheon provided To register for this event please CONFERENCE AGENDA AS AT 09.01.13 (To be updated once presentation speakers are confirmed) 12:30 Registration & Lunch 14:00 Keynote speaker - Richard Penny, Senior Fund Manager - Legal and General 14:15 Shares Magazine presentation - Russ Mould, Editorial Director 14:30 Company presentation - David Richards, President & CEO - WANdisco 14:45 Company presentation - Henrik Bang, CEO - Netcall 15:00 Company presentation - Marcus Hanke, CEO - 1Spatial 15:15 Company presentation - tbc 15:30 Coffee Break 16:00 Company presentation - Stephen Blundell, CFO - eServGlobal 16:15 Company presentation - David Baynes, CEO - Fusion IP 16:30 Company presentation - Stephen Streater, CEO - Forbidden Technologies 16:45 Company presentation - Charles Cohen, CEO - Probability 17:00 Company presentation - Simon Smith, Non-Executive Director - Cyan Holdings 17:15 Close This agenda is subject to change and alterations For further information, please visit our |
Posted at 28/9/2012 11:12 by ceohunter Fusion IP - Proactive Investors Presentation - 27th September |
Posted at 24/9/2012 09:53 by aim_trader 9:01 amFusion IP primed to put together more 'newcos' AIM-quoted Fusion IP has etched out a business as an investor in early stage technology companies borne out of Britain's research institutions and universities. |
Posted at 08/5/2012 13:43 by lucky_punter Harry Norman from Proactive Investors talks to David Baynes, CEO of Fusion IP, listed on the AIM market financial services sector; stock ticker FIP; share price 70 pence; market capitalisation 51 million pounds sterling. www.fusionip.co.uk. |
Posted at 08/9/2011 12:24 by ceohunter Click below for FIP's investor presentation from last night's Proactive Investors One2One Forum: |
Posted at 30/8/2011 10:33 by ceohunter * Proactive Investors One2One Investor Forums *The directors of Biome Technologies (AIM: BIOM), Fusion IP (AIM: FIP), Mountfield Group (AIM: MOGP) and ZincOx Resources (AIM: ZOX) will be presenting on: Wednesday the 7th September 2011 Venue: Chesterfield Mayfair Hotel, 35 Charles Street, Mayfair, W1J 5EB (Charles Suite) The presentations will start at 6:00pm and finish at approx 8:00pm. After the presentations are complete the directors will also be available to take questions during a free canapé and wine reception. REGISTER YOUR ATTENDANCE HERE: |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
